DNMT3A and laryngotracheoesophageal cleft: Results showed that the autoantibodies against DNMT3A and HSP60 showed higher expression in the LC group compared to the HCC, one possible reason could be that most of the LC patients retained the pre-cancer status and were prone to generate greater anti-TAA immune reactivities.